Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma

References

• Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children – a review. J Pediatr Endocrinol Metab 1997; 10: 561–8
   PubMedGoogle Scholar
• Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005; 365: 2014–23
   PubMed Web of Science ®Google Scholar
• Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol 1998; 31: 91–5
   PubMedGoogle Scholar
• Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D, et al. Unlocking pathology archives for molecular genetic studies: A reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest 2006; 86: 398–408
   PubMedGoogle Scholar
• Tucker MA, Jones PH, Boice JD, Jr, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991; 51: 2885–8
   PubMed Web of Science ®Google Scholar
• Vane D, King DR, Boles ET, Jr. Secondary thyroid neoplasms in pediatric cancer patients: Increased risk with improved survival. J Pediatr Surg 1984; 19: 855–60
   PubMedGoogle Scholar
• Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville MB, Rai SN, et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg 2003; 38: 1574–80
   PubMed Web of Science ®Google Scholar
• Smith MB, Xue H, Strong L, Takahashi H, Jaffe N, Ried H, et al. Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993;28:1342–8; Discussion 1348–9.
   PubMed Web of Science ®Google Scholar
• de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin MA, Schlienger JY, et al. Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatment. Br J Cancer 1999; 79: 1884–93
   PubMed Web of Science ®Google Scholar
• Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 1999; 131: 738–44
   PubMed Web of Science ®Google Scholar
• de Vathaire F, Francois P, Hill C, Schweisguth O, Rodary C, Sarrazin D, et al. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 1989; 59: 792–6
   PubMed Web of Science ®Google Scholar
• van Santen HM, Vulsma T, Dijkgraaf MG, Blumer RM, Heinen R, Jaspers MW, et al. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 2003; 88: 3657–63
   PubMedGoogle Scholar
• Paulides M, Dorr HG, Stohr W, Bielack S, Koscielniak E, Klingebiel T, et al. Thyroid function in paediatric and young adult patients after sarcoma therapy: A report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) 2007; 66: 727–31
   PubMedGoogle Scholar
• Moppett J, Oakhill A, Duncan AW. Second malignancies in children: The usual suspects?. Eur J Radiol 2001; 38: 235–48
   PubMed Web of Science ®Google Scholar
• Cardis E, Richardson D, Kesminiene A. Radiation risk estimates in the beginning of the 21st century. Health Phys 2001; 80: 349–61
   PubMedGoogle Scholar
• Huda W, Atherton JV, Ware DE, Cumming WA. An approach for the estimation of effective radiation dose at CT in pediatric patients. Radiology 1997; 203: 417–22
   PubMedGoogle Scholar
• Fearon T, Vucich J. Normalized pediatric organ-absorbed doses from CT examinations. AJR Am J Roentgenol 1987; 148: 171–4
   PubMedGoogle Scholar
• Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176: 289–96
   PubMed Web of Science ®Google Scholar
• Salvatore G, De Falco V, Salerno P, Nappi TC, Pepe S, Troncone G, et al. BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res 2006; 12: 1623–9
   PubMed Web of Science ®Google Scholar
• Sattler M, Salgia R. Targeting c-Kit mutations: Basic science to novel therapies. Leuk Res 2004; 28(Suppl 1)S11–S20
   Google Scholar